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ABSTRACT
Background and Aims Pancreatitis presents with significant risk for morbidity and mortality acutely. The purpose of this study was to 
evaluate demographics, comorbidity burden, and hospital characteristics and their effect on in-hospital mortality in patients with acute 
pancreatitis. Methods Data was collected from The National Hospital Discharge Survey for patients admitted for acute pancreatitis from 
2001-2010. Patients were separated into those who suffered in-hospital mortality and those that were discharged. Data was analyzed 
regarding demographics, length of stay, comorbidity burden, mortality, principal payment, and hospital size. Statistical comparisons 
were made using SPSS with chi-square and student T tests with a significance level of 0.05. Results 27,259 cases of acute pancreatitis 
were identified, with 573 who suffered in-hospital mortality. The mortality group was significantly older and had a longer length of stay. 
Patients with four or more comorbidities had a higher mortality rate (2.5%) compared to those with three or less (0.1%) (p<0.001). 
Region displayed a difference in mortality, with the Midwest showing a lower rate (1.6%) compared to all other regions. Mortality was 
lowest in small hospitals. Hospital ownership, however, did not show any significant differences in mortality. There was a difference 
in mortality rate when comparing principal forms of payment (p<0.001), with Medicare and Medicaid patients having the highest 
mortality rates. Conclusions Pancreatitis poses significant implications in morbidity and mortality in the acute setting. This study 
shows that factors such as age, length of stay, comorbidity burden, principal source of payment, and regional demographics have an 
impact on in-hospital mortality.
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INTRODUCTION
Acute pancreatitis (AP) is an inflammatory process 
of the pancreas that affects approximately 4.9 to 35 per 
100,000 in the general population [1]. It is the leading 
cause of gastrointestinal hospital admission [2]. A large 
epidemiological study found that between 1988 and 2003, 
the mortality from acute pancreatitis decreased from 12% to 
2% with a higher incidence of mortality among black males 
in their early 50’s [3]. Overall mortality of patients with acute 
pancreatitis admitted to the hospital is estimated to be 5% to 
10% varying from 3% in mild AP to 30% in severe AP [4, 5].
With significant risk of morbidity and mortality 
associated with acute pancreatitis, multiple scoring 
systems have been developed to assess its severity. 
However, no single scoring system has been shown to be 
superior to others in predicting in-hospital mortality [6, 
7]. One of the early systems, Ranson’s criteria, focuses 
on 11 factors with 5 assessed at the time of admission 
and 6 assessed 48 hours into admission. For scores <3, 
mortality was estimated to be 0% to 3%, scores ≥3 were 
associated with a 11% to 15% mortality, and scores ≥6 
were associated with a 40% mortality. Although used 
widely, a meta-analysis showed that Ranson’s criteria had 
poor predictive value for acute pancreatitis severity [8].
Acute Physiology and Chronic Health Examination 
(APACHE) II, another cumbersome scoring system, was 
developed for use with critically ill patients, limiting 
its applicability. The APACHE II score uses age and 12 
physiologic measures and can be calculated each day. 
Several studies have shown that an APACHE II score of less 
than 8 has a mortality rate <4% while a score greater than 
8 results in mortality between 11% to 18% [5, 9].
Bedside Index of Severity in Acute Pancreatitis (BISAP) 
is a simpler calculation for determining early in-hospital 
mortality of patients admitted for acute pancreatitis. A 
BISAP score uses point assignments: 1 point for each of the 
following - BUN >25 mg/dL, abnormal mental status with 
Glasgow Coma Scale score <15, evidence of Systematic 
Inflammatory Response Sydrome (SIRS), >60 years of age, 
and imaging revealing pleural effusion. Patients with a 
score of zero have less than 1% mortality while a score of 
3 to 5 is associated with >15% mortality. 
A recent validation study found that BISAP had similar 
performance to APACHE II and Ranson’s criteria [10]. 
Moreover, BISAP compares favorably with newer scoring 
systems for bedside AP assessment, such as the “harmless 
acute pancreatitis score” and the “CT severity index” [10, 11].
In sum, AP severity scores are often unwieldy to measure 
and may require recalculation at later times during the 
hospital admission. In contrast, rather than focus on an 
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AP score or index, other studies have investigated patient 
demographics (e.g., age), clinical characteristics (e.g., BMI, 
SIRS), various laboratory values, and radiological findings 
to determine AP severity and risk of mortality [12, 13, 14].
We examined selected demographic factors, 
comorbidities, and health care system characteristics that 
might be predictors of morality in hospitalized patients 
with acute pancreatitis.
METHODS
Study data was acquired from the National Hospital 
Discharge Survey (NHDS), which is collected every year 
through the National Center for Health Statistics. 
The NHDS collects patient hospitalizations and 
discharges from nonfederal hospitals across the United 
States with average length of stay of <30 days and ≥6 beds. 
Patient data in the NHDS is de-identified and made available 
to the public via the Center for Disease Control, making it 
exempt from an Institutional Review Board. The NHDS 
database was searched using International Classification 
of Diseases – Ninth Revision (ICD-9) diagnosis codes for 
patients admitted to hospitals with acute pancreatitis 
(ICD-9 code 577.0) from 2001-2010. For all patients 
included in the study, the following data was obtained: 
patient demographics (age, sex, race, marital status), 
hospital length of stay (LOS), hospital size (by number of 
beds), location/ownership (proprietary, government, or 
church/nonprofit), type of admission (emergency/urgent/
elective), source of admission, comorbidity burden, and 
mortality. This cohort was separated into two groups: 
those who died during the hospitalization and those who 
survived the hospitalization.
Means and standard deviations are reported for 
continuous variables, and counts and percents for 
categorical variables. The independent samples Mann-
Whitney Test was used for comparisons involving the two 
groups (mortality vs. no mortality) and a second variable 
measured on a continuous scale. The chi square test was 
used to compare the two groups on categorical variables. 
Inferences for these univariate statistical tests were made 
at the 0.05 level of significance with no corrections for 
multiple comparisons. Multivariable logistic regression 
was used to identify independent risk factors of mortality. 
Data was first recorded in Excel, and analyses were conducted 
using IBM SPSS Statistics 23.0 (IBM, Armonk, NY).
RESULTS
Table 1 shows the results for 27,259 patients admitted 
for acute pancreatitis during the 2001-2010 periods. Of 
this group, 573 (2.1%) suffered in-hospital mortality. The 
mean age of patients who died was 64.5 years, which was 
significantly higher than the survival group’s mean age of 
51.8 years (p<0.001). Only two races had a large number 
of patients: white (n=13,610) and African-American/
black (n=4984), and there was no difference in mortality 
between these two groups (white 2.3% vs. A-A/black 
2.2%; p=0.55).
Mean length of stay was nearly double (12.0 vs. 6.4 
days, p<0.001) in the mortality group. Patients with four 
or more comorbidities had a significantly higher mortality 
rate (2.5%) compared to those with three or fewer 
comorbidities (0.1%) (p<0.001).
Mortality was greater as hospital size increased, 
with the largest hospitals having the highest mortality 
rate (2.6%) and the smallest hospitals having the lowest 
mortality rate (1.3%) (p<0.001). Mortality did not differ 
by type of hospital ownership (p=0.49). Of the 10 principal 
forms of payment, Medicare patients had significantly 
higher mortality (3.6%) than patients with other insurers 
– e.g., Medicaid (2.0%), HMO/PPO (1.4%), and self-pay 
(1.0%) (p<0.001). 
Mortality did not differ by type of admission (emergency 
n=18,382; urgent n=4,287; and elective n=1,729). Elective 
patients had a mortality rate of 2.8%, emergency 2.1%, and 
urgent 1.8% (p=0.06). The hospitals in the Midwest had a 
lower mortality rate (1.6%) compared to the Northeast 
(2.5%), South (2.2%), and West (2.4%) (p=0.002). 
Multivariable logistic regression (MLR) analysis was 
used to identify independent predictors of mortality. 
Predictors entered into the MLR equation were: age, sex, 
race (white, African-American, other), comorbidities (3 
or fewer, 4 or more), admission type (emergency, urgent, 
elective), hospital length of stay, hospital region (Midwest, 
other 3 regions), hospital size (99 or fewer beds, 100 or 
more beds), hospital ownership (proprietary, government, 
church/nonprofit), and principal payment (Medicare, 9 
other insurers)
Table 2 shows the six independent risk factors. 
The highest adjusted odds ratio (AOR) was four or 
more comorbidities (AOR=15.22 [95% CI=4.87-47.54]; 
p<0.001), followed by hospital size of 100 beds or more 
(AOR=1.42 [95% CI=1.04-1.95]; p=0.029), Midwest 
region (AOR=1.31 [95% CI=1.05-1.64]; p=0.017), male 
sex (AOR=1.26 [95% CI=1.05-1.52]; p=0.015), increasing 
age (AOR=1.03 [95% CI=1.03-1.04]; p<0.001), and longer 
hospital LOS (AOR=1.03 [95% CI=1.02-1.03]; p<0.001).
DISCUSSION
Using the National Hospital Discharge Survey (NHDS) 
database, we identified six independent risk factors of 
in-hospital mortality in acute pancreatitis patients: four 
or more comorbidities, larger hospital size, treatment 
outside the Midwest region, male sex, older age, and longer 
hospital length of stay. 
Our finding that AP patients with four or more 
comorbidities are at increased risk of mortality is in 
agreement with earlier studies [15, 16, 17]. Singh et al. 
found a number of associations between various comorbid 
conditions and mortality in patients with interstitial 
pancreatitis [15]. Frey et al. reported that an increasing 
number of chronic comorbidities were associated with 
higher morality for acute pancreatitis [16]. These authors 
also noted that older patients were more likely to die during 
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We found that in-hospital mortality varied by 
geographical location. Midwestern states had a lower 
mortality rate compared to Southern, Western, and 
Northeastern states. These regional differences amongst 
hospitals may be related to demographic (e.g., age), 
clinical (e.g., obesity, number of comorbidities), and 
socioeconomic (e.g., poverty) factors, population size, and 
number of medical facilities per capita. 
The scoring systems currently utilized to predict 
mortality in patients with acute pancreatitis are often 
inconvenient to calculate and do not facilitate efficient 
triaging. Investigators have used serum markers and 
radiological findings to predict AP severity and mortality. 
their hospitalization with AP. An epidemiological study 
conducted in Japan found that patients older than 70 years 
with severe comorbidities (>3 comorbid conditions) had 
twice the risk of in-hospital mortality [17]. Also, Murata 
et al. showed that cardiovascular and renal diseases are 
factors that increase hospital length of stay and mortality 
among AP patients [14]. With more comorbid conditions, 
patients increase their likelihood of developing end organ 
damage [18]. In our study, patients in the in-hospital 
mortality group had a longer LOS. However, due to 
multiple pre-existing comorbidities, those with longer LOS 
may have had more complications. Others have found that 
in-hospital mortality was higher in obese patients [19]. 
Characteristic Patients who did not die in the hospital Patients who died in the hospital P value
Number of patients 26686 573
Age (years) (mean ± SD) 64.52 ± 19.11 51.76 ± 19.09 <0.01
Sex
    Male (percent) 13195 (97.8%) 303 (2.2%) 0.1
    Female (percent) 13491 (98%) 270 (2.0%)
Race
   Caucasian (percent) 13292 (97.7%) 318 (2.3%) 0.55
   African-Americans (percent) 4875 (27.8%) 109 (2.2%)
Length of Stay (days) (mean ± SD) 12.02 ± 16.28 6.37 ± 7.96 <0.001
Number of comorbidities
     Three or less 4281 (99.9%) 4 (0.1%) <0.001
     Four or more 22405 (97.5%) 569 (2.5%)
Region
     Northeast 4934 (97.5%) 129 (2.5%) 0.002
     Midwest 7909 (98.4%) 131 (1.6%)
     South 10470 (97.8%) 231 (2.2%)
     West 3373 (97.6%) 82 (2.4%)
Number of beds in hospital
     6-99 3869 (98.7%) 50 (1.3%) <0.001
     100-199 6266 (97.9%) 134 (2.1%)
     200-299 6346 (98%) 131 (2%)
     300-499 7200 (97.6%) 177 (2.4%)
     >500 3005 (97.4%) 81 (2.6%)
Hospital Ownership
    Proprietary 2606 (98%) 52 (2%) 0.49
    Government 2606 (97.6%0 64 (2.4%)
    Nonprofit or church 21474 (97.9%) 457 (2.1%)
Principal forms of payment
    Workers compensation 15 (100%) 0 (0%) <0.001
    Medicare 8436 (96.4%) 316 (3.6%)
    Medicaid 4177 (98%) 85 (%)
    Other government 422 (98.4%) 7 (1.6%)
    Blue cross/Blue shield 2576 (98.9%) 29 (1.1%)
    HMO/PPO 4429 (98.6%) 61 (1.4%)
    Other Private Insurance 2747 (98.8%) 33 (1.2%)
     Self-pay 2565 (99%) 27 (1%)
     No charge 204 (99.5%) 1 (0.5%)
     Other 746 (99.2%) 6 (0.8%)
     Not stated 369 (97.9%) 8 (2.1%)
Type of Admission
    Emergency 18000 (97.9%) 382 (2.1%) 0.19
    Urgent 4210 (98.2%) 98.2 (1.8%)
    Elective 1681 (97.2%) 48 (2.8%)
    Not available 2794 (97.7%) 66 (2.3%)  
Table 1. Characteristics evaluated for differences in mortality in acute pancreatitis.
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To our knowledge, no prior research has used the NHDS 
database to examine demographic factors, comorbidities, 
and health care system characteristics that may be 
related to in-hospital mortality in patients with acute 
pancreatitis.
While type of hospital ownership (proprietary, 
government, or owned by a non-profit organization or 
church) had similar rates of in-patient mortality, smaller 
hospitals had lower mortality rates. Smaller hospitals 
may manage primarily milder cases of acute pancreatitis 
with patients having severe pancreatitis and related 
complications transferred to large facilities more capable 
of handling critically ill patients. Future investigations of 
facility transfer related to pancreatitis may reveal why 
mortality is lower in smaller hospitals. 
Additionally, patients with Medicare as their primary 
insurance had higher in-hospital mortality compared 
to other forms of payment. However, the Medicare/
mortality relationship found with the univariate analysis 
was not significant in the multivariable model. As 
mentioned earlier, unfavorable demographic, clinical, and 
socioeconomic factors may be more prevalent in Medicare 
patients than with those having commercial and private 
insurance coverage. 
Mortality among elective and emergency admissions 
was marginally higher than urgent admissions, but neither 
hospitalization for elective or emergency reasons was 
an independent predictor when urgent admission was 
used as the reference standard. Emergency admissions 
receive aggressive treatment and higher acuity of care 
once admitted in comparison to those admitted electively. 
Without access to individual patient data, we were not able 
to examine clinical characteristics that might be related to 
the type of admission. 
Our study has several limitations. First, only non-federal 
hospitals were included in the National Hospital Discharge 
Survey database; thus, generalizability to Veterans Affairs 
medical centers and other institutions should be done with 
caution. Second, the NHDS database included readmissions 
for acute pancreatitis; thus, the unit of analysis for the study 
was events of AP and not independent patients with AP. 
Finally, the NHDS data did not include lab values, treatment 
choices, or longitudinal follow-up information; thus, the 
impact of clinical characteristics could not be examined. 
CONCLUSION
Our analysis of National Hospital Discharge Survey 
data shows that demographic factors (sex and age), 
clinical characteristics (comorbidities, length of stay), 
and features of the health care system (geographic 
location, hospital size) may be utilized as predictors 
of in-patient mortality for those diagnosed with acute 
pancreatitis. Future research may identify other 
predictors of mortality that would improve the scoring 
systems now used with acute pancreatitis patients. 
As more research is conducted, a more accurate, less 
cumbersome, and easily calculated scoring system may 
be developed aiding in the reduction of in-hospital 
mortality in patients with acute pancreatitis. 
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